These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9887499)

  • 1. [Obesity: entrance port to multimorbidity].
    Sailer D
    Wien Med Wochenschr; 1998; 148(17):388-92. PubMed ID: 9887499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamics of the male fat distribution pattern.
    Jern S
    Blood Press Suppl; 1992; 4():21-8. PubMed ID: 1345331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enlarged waist circumference and cardiovascular risk factors].
    Pataky Z; Bobbioni-Harsch E; Makoundou V; Golay A
    Rev Med Suisse; 2009 Mar; 5(196):671-2, 674-5. PubMed ID: 19462610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is visceral obesity the cause of the metabolic syndrome?
    Després JP
    Ann Med; 2006; 38(1):52-63. PubMed ID: 16448989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The obesity epidemic: pathophysiology and consequences of obesity.
    Pi-Sunyer FX
    Obes Res; 2002 Dec; 10 Suppl 2():97S-104S. PubMed ID: 12490658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship of different types of abdominal obesity to risk of metabolic syndrome].
    He HB; Zhao ZG; Pu YF; Chen J; Ni YX; Zhong J; Liu HY; Li YS; Yan ZC; Liu DY; Zhu ZM
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1251-4. PubMed ID: 18844097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Obesity in type 2 diabetes, its features and specificity].
    Xiang KS; Jia WP; Lu JX; Tang JL; Li J
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1768-72. PubMed ID: 15631769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
    Vona-Davis L; Howard-McNatt M; Rose DP
    Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Body fat distribution: its characteristics and relationship to cardiovascular risk factors in obese Chinese].
    Ran XW; Li XS; Tong NW; Li QF; Tang BD; Li XJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):699-703. PubMed ID: 15460424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and the metabolic syndrome.
    Johannsson G; Bengtsson BA
    J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents?
    Bacha F; Saad R; Gungor N; Arslanian SA
    Diabetes Care; 2006 Jul; 29(7):1599-604. PubMed ID: 16801585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melancholic depression and abdominal fat distribution: a mini-review.
    Mann JN; Thakore JH
    Stress; 1999 Aug; 3(1):1-15. PubMed ID: 19016189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and breast cancer risk.
    Sinagra D; Amato C; Scarpilta AM; Brigandì M; Amato M; Saura G; Latteri MA; Caimi G
    Eur Rev Med Pharmacol Sci; 2002; 6(2-3):55-9. PubMed ID: 12708611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.